Lung Biopsy Systems Market - Growth Drivers and Challenges
Growth Drivers
- Growing Geriatric Population– The elderly population is more prone to chronic lung diseases and the rising number of elderly populations across the globe is estimated to drive lung biopsy systems market growth. According to estimates, the number of individuals in the world who are 60 or older will increase to over 2 billion by 2050.
- Spiking Cases of COPD to Propel the Growth of the Market - COPD, a chronic obstructive pulmonary disease, is considered an inflammatory lung disease that is responsible for the interrupted airflow from the lungs and can result in the death of the affected person. COPD requires quick medical attention and early diagnosis to be cured thoroughly.
Challenges
- Possibility of Side Effects Such as Blood Loss and Pneumonia– In some patients, a lung biopsy will cause side effects such as blood clots or blood loss, pain, discomfort, infection, and pneumonia. These are estimated to hamper the market growth in the coming years as per the market analysis.
- Requirement of High Initial Investment
- Lack of Skilled Medical Professionals
Lung Biopsy Systems Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
15.3% |
|
Base Year Market Size (2025) |
USD 5.03 billion |
|
Forecast Year Market Size (2035) |
USD 20.89 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of lung biopsy systems is evaluated at USD 5.72 billion.
The global lung biopsy systems market size was worth over USD 5.03 billion in 2025 and is poised to grow at a CAGR of around 15.3%, reaching USD 20.89 billion revenue by 2035.
North America is set to command a 42% share of the Lung Biopsy Systems Market by 2035, propelled by the growing volume of research and clinical trials focused on new lung cancer treatment approaches.
Key players in the market include Argon Medical Devices, Inc., Fujifilm Corporation, Cardinal Health, Inc., DTR Medical Ltd, B. Braun Melsungen AG, Becton, Dickinson and Company, Olympus Corporation, Hologic Inc., Medtronic Limited, Zimmer Biomet Holdings, Inc.
